Keyphrases
Estrogen
100%
Pharmacological Intervention
100%
Non-alcoholic Fatty Liver Disease (NAFLD)
100%
Medical Intervention
100%
Liver
16%
Cirrhosis
16%
Therapeutic Approaches
16%
Treatment Strategy
16%
Public Health Risk
16%
Early Detection
16%
Liver Function
16%
Fibrosis
16%
Estrogen Signaling
16%
Hormonal Regulation
16%
Disease Pathogenesis
16%
Risk Stratification
16%
Personalized Therapy
16%
Postmenopausal Women
16%
Health Implications
16%
Novel Therapeutics
16%
Disease Management
16%
Comprehensive Intervention
16%
Dietary Modification
16%
Unveiling
16%
Cardiovascular Complications
16%
Targeted Intervention
16%
Metabolic Disorders
16%
Gut Microbiota
16%
Pharmaceutical Intervention
16%
Severe Disease
16%
Nonalcoholic Steatohepatitis
16%
Global Prevalence
16%
Improved Patient Outcomes
16%
Therapeutic Pathways
16%
Medicine and Dentistry
Medical Intervention
100%
Nonalcoholic Fatty Liver
100%
Lifestyle
100%
Prevalence
14%
Fibrosis
14%
Risk Stratification
14%
Liver Function
14%
Cardiovascular Disease
14%
Public Health
14%
Postmenopause
14%
Water-Electrolyte Imbalance
14%
Gut Microbiota
14%
Hormonal Regulation
14%
Disease Management
14%
Liver Cirrhosis
14%
Pharmacology, Toxicology and Pharmaceutical Science
Nonalcoholic Fatty Liver
100%
Disease
14%
Liver Cirrhosis
14%
Prevalence
14%
Cardiovascular Disease
14%
Fibrosis
14%
Intestine Flora
14%
Metabolic Disorder
14%